pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Carvykti · news · pharmadog
← back to Carvykti
News mentioning Carvykti
14
stories
8d
Chutes & Ladders—Former Legend CEO lands at K2
fiercebiotech
9d
Ex-Legend CEO takes helm at biotech startup scouring the globe for drugs
biopharma dive
16d
4 potential biotech M&A targets, plus a pretty sure bet from J&J
biospace
21d
Chutes & Ladders—Legend CEO departs without successor in place
fiercebiotech
21d
J&J nabs option to buy ‘in vivo’ CAR-T maker Sail for nearly $2.6B
biopharma dive
22d
J&J secures right to take the helm in up to $925M Sail CAR T pact
biospace
24d
FDA scientists question Capricor data; Legend CEO steps down
biopharma dive
25d
Legend CEO Ying Huang resigns; Carvykti chief named interim leader
endpoints
25d
Legend Biotech CEO abruptly steps down without permanent replacement
fiercebiotech
25d
Lilly, AbbVie climb aboard in vivo CAR T train—but safety remains a hurdle
biospace
Jul 22, 26
Repligen strikes $1.5B BioLife buyout to bag cell therapy product pharmas rely on
biospace
Jul 15, 26
J&J dips despite upbeat outlook; AstraZeneca, Spero cut China deals
biopharma dive
Jun 3, 26
Legend surges on early data for ‘in vivo’ lymphoma cell therapy
biopharma dive
Jun 2, 26
Legend Biotech shares first in vivo CAR-T data, its next act after Carvykti
endpoints
